Damage of non-vascularised tissues such as cartilage and cornea can result in healing processes accompanied by a non-physiological angiogenesis. Peptidic aptamers have recently been reported to block the vascular endothelial growth factor (VEGF). However, the therapeutic applications of these aptamers is limited due to their short half-life in vivo. In this work, an enhanced stability and bioavailability of a known VEGF blocker aptamer sequence (WHLPFKC) was pursued through its tethering of molecular scaffolds based on hyperbranched peptides, the poly(ɛ-lysine) dendrons, bearing three branching generations.
Introduction
The invasion of healthy joint and intervertebral disc cartilage by fibrous tissue in pathological conditions such as osteoarthritis and rheumatoid arthritis as well as in traumatic and degenerative conditions is a consquence of abnormal angiogenesis (Pulsatelli et al., 2013) .
Pathological angiogenesis is linked by biochemical signalling to the insurgence of the inflammation causing the progressive degeneration of cartilage (Bonnet and Walsh, 2005) . In clinics, non-steroidal anti-inflammatories drugs are administred to control inflammation and minimise joint damage, but these treatments neither improve the overall quality of life of the patient nor favour the repair of the degenerated tissue. The pathogenesis of other inflammatory disorders including synovial joints (Troken et al., 2007) and macular degeneration (AMD) (Xu et al., 2013) have also been associated to pathological angiogenesis, but appropriate therapies have not yet been identified (Carmeliet, 2003) .
However, it is widely accepted that drugs such as Sorafenib (Nexavar, Bayer) and Bevacizumab (Avastin TM , Genentech), acting directly on the prime driver in the process of blood vessel sprouting, i.e. the vascular endothelial growth factor (VEGF), have been sucessfully used to control angiogenesis (Bischoff and Griffioen, 2008) . Indeed, clinical therapies commonly target VEGF either to decrease its levels or to block its activation and any subsequent downstream signaling pathway (Kim et al., 2011) . It has also been ascertained that the therapeutic efficacy of the various VEGF blockers available can be improved only by ensuring: (i) directed targeting of the effect of the blocker on endothelial cells (ECs) and (ii) the increased in situ retention of the blocker protracting the effect in the degenerated tissue (Wang, 2003) .
To this end, the search for new anti-angiogenic agents of enhanced therapeutic efficacy has more recently been directed towards aptamers. Aptamers are oligonucleotides such as ribonucleic acid (RNA) and single-strand deoxyribonucleic acid (ssDNA) who have shown
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high binding affinitiy towards a wide range of extra-and intracellular molecular targets (e.g.
proteins, peptides or even cells) (Tuerk and Gold, 1990) . Among them, synthetic peptidic aptamers have shown greater value in the treatment of vascular disorders (e.g. WHLPFKC sequence) (Erdag et al., 2007) , but their clinical use is restricted by their relatively short halflife in vivo (Nugent and Edelman, 2003) In the pursuit of enhancing their retention time in target tissues and anti-angiogenic effects, dendrons ensuring a multiple and spacially-ordered presentation of of the anti-angiogenic linear VEGF blocker peptide WHLPFKC have previously been investigated (Meikle et al., 2011 (Meikle et al., 2011) .
These findings appear to offer future therapeutic opportunities when combined with the recent discovery of the properties of a novel hydrogels, the ionic-crosslinked methacrylated gellan gum (iGG-MA) hydrogels that was firstly described by Silva-Correia et al. (2011; 2012a-b; 2013a-b) . The effects of combining the iGG-MA hydrogel discs with FFGen 3 K(WHLPFKC) 16 has recently been studied in an ovine nucleotomy model showing a significant improvement in the regeneration of tissues with physicological features (Reitmaier et al., 2014) .
The present study aims to demonstrate the high level of control over angiogenesis offered by iGG-MA hydrogels loaded with the VEGF blocker dendrons. It compares the efficacy of this 
Materials and Methods

VEGF Blocker Synthesis and Characterisation
Poly-(ɛ-lysine) dendrons (Gen 3 K) were synthesised with a di-phenylalanine core molecule (FF), a L-lysine core consisting of three levels of branching and a tethering with sixteen linear VEGF blocker peptide (WHLPFKC) 16 exposed at their uppermost branching generations as previously reported by Meikle et al. (2011) . Briefly, the synthesis of both the water/0.1 % Trifluoroacetic Acid) and a Solvent B (Acetonitrile/0.1 % Trifluoroacetic acid).
The eluate was visualised by UV light lamp at 230 nm (UVP Chromato-vue Cabinet). The collected peak fractions were identified by ESI-TOF mass spectrometry (Bruker microTOF).
Preparation of VEGF Blocker-Functionalised iGG-MA hydrogel discs
iGG-MA hydrogel discs were prepared according to an established protocol ( was analysed by capturing images at 10x magnification from six different fields for each experimental well using a phase contrast microscopy (Nikon Eclipse TE2000-U) fitted with a digital camera (Nikon D1X). Whereas, to the purpose of monitoring the blocker release between iGG-MA and the surrounding Matrigel matrix, all samples were fixed with 4% (v/v) paraformaldehyde (Fisher Scientific) for 10 minutes at room temperature, followed by washing in water and staining with haematoxylin and eosin stain (H&E). Specimens were then observed under a phase contrast microscopy (Nikon Elipse TE 200U) and images captured using a digitised camera at 10 and 20x magnification (Canon LM Scope).
Quantitative Analysis of Endothelial Cell Sprouting
Due to the faster rate of diffusion of the linear form from the iGG-MA hydrogel mesh, quantitative analyses were performed on FFGen 3 K (WHLPFKC) 16 -laden iGG-MA samples versus control ones.
Light microscopy images (8-bit) were analysed using a specific image-processing software, Image J/Analyze Skeleton (http://fiji.sc/AnalyzeSkeleton). The programme allowed the automated measurement of the mean value of sprouting length, number of free un-and associated termination points and junctions within an endothelial capillary-like network. This was obtained by skeletonising each EC sprout into a more compact representation while preserving the main features of the original image ( Figure 1 ) (Valapala et al., 2011) .
Based on the H&E-stained images (n=6), the number of EC nuclei per capillary-like structure was also counted after marking each nucleus as a black dot for easier identification and finally reported in an Excel file format.
CAM Model and Tissue Specimen Preparation
White fertilised chicken eggs (n=5, Pintobar, Portugal) were incubated at 37°C (Laboratory Incubator Series 8000, Termaks) for 3 days. Afterwards, albumen of 2.5 mL was extracted using a sterile syringe while the CAM of the fertilised egg was separated from the top part of the shell. This formed a small visible window (maximum of 15 mm in diameter) that allowed the easy evaluation and access to the CAM. The hole was sealed using a transparent tape (50x30 mm; BTK) to the purpose of preventing dehydration and any damage of the embryonic tissues. The eggs were placed at 3°C and 60% humidity until day 10 of embryonic development. At this time point, both non-and aptamer-functionalised iGG-MA discs were 
Blood Vessel Identification by H&E and Lectin Staining
Paraffin sections were de-waxed with xylene (National Diagnostic) and ethanol (Fisher Scientific) for 10 minutes, followed by washing in water and by staining with hematoxylin overnight. Afterwards, all the slides (n=6) were carefully rinsed with distilled water and imaged using a confocal laser scanning microscopy (Leica UK), whereas signals were recorded in the green channel with an excitation 488 nm and emission 522 nm.
Morphometric Image Analysis
Morphometric image analysis was performed according to a published method (Gresta et al., 2014) 
Statistical Analysis
All results from both in vitro and in ovo experiments were tested for statistical difference using one-way analysis of variance (ANOVA). A p value ≤ 0.05 was accepted as statistically significant for a 95% confidence interval while data were expressed as means ± standard
deviation (SD).
Results
In vitro Sprouting Inhibition Test at the iGG-MA Material/Tissue Interface
The results showed that iGG-MA hydrogel discs prevented EC tube infiltration (Figure 3 ).
However, when the hydrogels were functionalised with both linear and VEGF blocker dendrons their anti-angiogenic capacity to inhibit HUVEC sprouting formation was expanded to the surrounding tissue and, in the case of the VEGF blocker dendron, confined to the iGG-MA/tissue boundary after both 24 and 48 hours incubation (Figure 3, dashed lines) . Instead, a more extended area of inhibition was observed in the case of hydrogels pre-loaded with linear WHLPFKC in which a relatively rapid diffusion of the peptides from the iGG-MA hydrogel discs to the surrounding Matrigel led to an inhibition of the sprouting already after 24 hours ( Figure 3 , grey arrows). This trend was more pronounced at 48 hours compared to that of 
CAM of iGG-MA and Dendron-laden iGG-MA Hydrogel Discs
Both non-and aptamer -laden iGG-MA hydrogel discs were well-tolerated by the host tissue membrane after implantation as no necrosis or significant host response was detected. Light microscopy analysis of the non-treated samples revealed the presence of elongated blood vessels that longitudinally converged towards the material at the tissue/iGG-MA interface FFGen 3 K(WHLPFKC) 16 -functionalised iGG-MA samples =135± 3.2 vessels/µm 2 ) of the two tested samples as illustrated in Figure 7 A. Moreover, the total number of blood vessels was found to be similar throughtout the tissue undergoing the implants of both non-andfunctionalised hydrogels (Figure 7 B ).
Discussion
A known VEGF blocker sequence has been integrated at the uppermost branching generation of dendrons that have specifically been designed to enhance availability of the biospecific aptamers and to improve retention in and controlled delivery from hydrogels for tissue engineering. The tailor-made design had already shown the clinical potential of this novel class of aptamers (Meikle et al., 2011) . They were based on the amino acid lysine which contains an alkyl amino side-chain capable to allow the branching into a larger macromolecule with an overall structure presenting the biospecific sequences at relatively high density and in an orderly-spaced manner to the surrounding biological microenvironment. This type of dendron was assembled using a new microwave-assisted SPPS to expose an increased density of anti-angiogenic peptide sequence (WHLPFKC) at their uppermost branching generation (Meikle et al., 2011) . WHLPFKC has been recently isolated by phage display technique (Erdag et al., 2007) and demonstrated to be capable of establishing a bond with human VEGF 165 at molar ratio of 1:1 even in presence of both Type I and II collagen [our unpublished data] . Forming a stable complex with the angiogenic growth factor, this linear peptide essentially antagonised the autocrine VEGF effects on
HUVECs in vitro. However, when grafted to a dendron scaffold, its bioavailability and biological actvity was successfully maximised providing evidence for the control of proliferation and regression of capillary-like structures in HUVECs. Moreover, the relatively hydrophobic nature of these VEGF blocker dendrons enhances their potential to penetrate collagenous matrices and to revert angiogenesis in absence of cytotoxicity (Meikle et al., 2011) . On the basis of this evidence, the tailored-design of the material in the present study enabled a control over the release of VEGF blocker sequences by: (i) reducing the problem of burst release from the gel associated with the relatively smaller linear aptamer through an increase of the molecular weight and through the enhancement of physical interactions between the di-phenylalanine groups at the root of the dendrons and the methacrylate hydrophobic residues of the iGG-MA and (ii) increasing the density and space distribution of the aptamer through the exposure of sixteen units per dendrimer. Although specific rheological studies were not investigated in this paper, it was observed that the hydrogel formed a more compact structure when dendrons were encapsulated in it supporting the occurrence of hydrophobic interaction within the gel mesh. This more compact structure of This article is protected by copyright. All rights reserved. observed in vitro and in line with other studies demonstrating the key role of VEGF concentration gradients in angiogenesis (Shamloo et al., 2012) . The qualitatively-assessed reduction in MVD at the boundary of aptamer-functionalised iGG-MA samples, but not in the central areas, is corroborated by previous work showing similar findings in cases where vessel morphology and size changed with interferences in the local VEGF concentration levels (Ozawa et al., 2004) . These authors found that low VEGF expression induced destabilised retinal capillaries gradually regressing rather than progressing into angiogenesis.
The disruption of the interaction of the VEGF molecule with its receptor on the endothelial cell membrane appeared to be one of the determinants in this critical event (Nakatsu et al., 2003) . Although in our results the average number of capillaries was not significantly different between analysed samples, recent genetic studies in mice have reported that targeting blood vessel function and stabilisation, rather than their numbers, may provide an alternative approach to prevent angiogenesis in tissue regeneration (Loges et al., 2010; Alvarez et al., 2009) .
Conclusions
In this study, FF-Gen 3 K(WHLPFKC) 16 showed to represent a potentially useful biofunctionalisation strategy to enhance the clinical performance of cartilage tissue engineering based on iGG-MA hydrogel discs. The fine control of angiogenesis around the gel boundary is likely to impede the invasion of blood vessels from the surrounding vascularised tissue independently from its tight mesh. As the biomaterial is absorbed and new tissue is formed, it is likely that angiogenesis will not overcome avascular cartilage as its penetration will no longer be stopped by the tight mesh, but rather by the sustained but circubscribed release of the aptamer; a property that cannot be achieved by the use of the small molecular weight, linear VEGF blocker WHLPFKC.
